Assessment of insulin resistance and metabolic syndrome in young reproductive aged women with polycystic ovarian syndrome: analogy of surrogate indices

References

• Abruzzese, G.A., et al., 2017. Lipid accumulation product (LAP) and visceral adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Hormone and metabolic research, 49, 23–29.
   PubMed Web of Science ®Google Scholar
• Amato, M.C., et al., 2010. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes care, 33 (4), 920–922.
   PubMed Web of Science ®Google Scholar
• Baldani, D.P., Skrgatic, L., and Ougouag, R., 2015. Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women. International journal of endocrinology, 2015, 1–17.
   Web of Science ®Google Scholar
• Carmina, E. and Lobo, R.A., 1999. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. The journal of clinical endocrinology & metabolism, 84 (6), 1897–1899.
   PubMed Web of Science ®Google Scholar
• Chan, J.L., et al., 2017. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. American journal of obstetrics and gynecology, 217 (2), 189.e1–189.e8.
   Web of Science ®Google Scholar
• Cirik, D.A. and Dilbaz, B., 2014. What do we know about metabolic syndrome in adolescents with PCOS? Journal of the Turkish German Gynecological Association, 15, 49–55.
   PubMedGoogle Scholar
• Conway, G., et al., 2014. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European journal of endocrinology, 171 (4), P1–P29.
   PubMed Web of Science ®Google Scholar
• Ding, T., et al., 2017. The prevalence of polycystic ovary syndrome in reproductive aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget, 8 (56), 96351–96358.
   PubMedGoogle Scholar
• Jatzko, B. and Ott, J., 2011. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertility and sterility, 96 (4), e158.
   PubMed Web of Science ®Google Scholar
• Kahn, H.S., 2005. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC cardiovascular disorders, 5 (1), 26.
   PubMedGoogle Scholar
• Luque-Ramirez, M. and Escobar-Morreale, H.F., 2014. Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity. Current hypertension reports, 16, 500.
   PubMed Web of Science ®Google Scholar
• March, W.A., et al., 2010. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human reproduction, 25 (2), 544–551.
   PubMed Web of Science ®Google Scholar
• Marciniak, A., et al., 2016. Cardiovascular system diseases in patients with polycystic ovary syndrome – the role of inflammation process in this pathology and possibility of early diagnosis and prevention. Annals of agricultural and environmental medicine, 23 (4), 537–541.
   PubMed Web of Science ®Google Scholar
• Maturana, M.A., Moreira, R.M., and Spritzer, P.M., 2011. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women. Maturitas, 70 (4), 395–399.
   PubMed Web of Science ®Google Scholar
• Misra, A., 2015. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association Position Statement. Diabetes technology and therapeutics, 17 (9), 667–671.
   PubMed Web of Science ®Google Scholar
• Nascimento, J.X., et al., 2015. Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids in health and disease, 14 (1), 62.
   PubMed Web of Science ®Google Scholar
• Padmanabhan, V., 2009. Polycystic ovary syndrome – “A riddle wrapped in a mystery inside an enigma”. The journal of clinical endocrinology & metabolism, 94 (6), 1883–1885.
   PubMed Web of Science ®Google Scholar
• Papadakis, G., et al., 2017. Is cardiovascular risk in women with PCOS a real risk? Current insights. Minerva endocrinologica, 42 (4), 340–355.
   PubMed Web of Science ®Google Scholar
• Perona, J.S., et al., 2017. Waist circumference shows the highest predictive value for metabolic syndrome, and waist-to-hip ratio for its components, in Spanish adolescents. Nutrition research, 45, 38–45.
   PubMed Web of Science ®Google Scholar
• Radikova, Z., et al., 2006. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Experimental and clinical endocrinology and diabetes, 114 (05), 249–256.
   PubMed Web of Science ®Google Scholar
• Ramachandran, A., 2004. Diabetes & obesity – the Indian angle. Indian journal of medical research, 120 (5), 437–439.
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani, F., Minooee, S., and Azizi, F., 2014. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. European journal of endocrinology, 171 (2), 199–207.
   PubMed Web of Science ®Google Scholar
• Randeva, H.S., et al., 2012. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine reviews, 33 (5), 812–841.
   PubMed Web of Science ®Google Scholar
• Rashid, N., et al., 2017. Association of IL-1β, IL 1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome. Inflammation research, 66, 1–16.
   PubMed Web of Science ®Google Scholar
• Saxena, P., Prakash, A., and Nigam, A., 2011. Efficacy of 2-hour post glucose insulin levels in predicting insulin resistance in polycystic ovarian syndrome with infertility. Journal of human reproductive sciences, 4 (1), 20–22.
   PubMedGoogle Scholar
• Tang, Q., et al., 2015. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug discoveries & therapeutics, 9 (6), 380–385.
   PubMed Web of Science ®Google Scholar
• [NCEP] Third Report of the National Cholesterol Education Program, 2002. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 106 (25), 3143–3421.
   PubMed Web of Science ®Google Scholar
• Tola, E.N., Yalcin, S.E., and Dugan, N., 2017. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women. European journal of obstetrics & gynecology and reproductive biology, 214, 168–172.
   PubMed Web of Science ®Google Scholar
• Torchen, L.C., 2017. Cardiometabolic risk in PCOS: more than a reproductive disorder. Current diabetes reports, 17 (12), 137.
   PubMed Web of Science ®Google Scholar
• Wehr, E., et al., 2011. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. The journal of clinical endocrinology and metabolism, 96 (6), E986–E990.
   PubMed Web of Science ®Google Scholar
• Wild, R.A., et al., 2010. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. The journal of clinical endocrinology and metabolism, 95 (5), 2038–2049.
   PubMed Web of Science ®Google Scholar
• Wiltgen, D., et al., 2009. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Human reproduction, 24 (7), 1726–1731.
   PubMed Web of Science ®Google Scholar
• Xia, C., et al., 2012. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. European journal of clinical nutrition, 66 (9), 1035–1038.
   PubMed Web of Science ®Google Scholar
• Yildiz, B.O., et al., 2012. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Human reproduction, 27 (10), 3067–3073.
   PubMed Web of Science ®Google Scholar